The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simarro, M.
Right arrow Articles by Lozano, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simarro, M.
Right arrow Articles by Lozano, F.

The Journal of Immunology, Vol 159, Issue 9 4307-4315, Copyright © 1997 by American Association of Immunologists


ARTICLES

The cytoplasmic domain of CD5 mediates both TCR/CD3-dependent and - independent diacylglycerol production

M Simarro, C Pelassy, J Calvo, L Places, C Aussel and F Lozano
Servei d'Immunologia, Hospital Clinic, Barcelona, Spain.

CD5 is a 67-kDa surface glycoprotein found in association with the Ag receptor complex on both T and B lymphocytes. CD5 modulates Ag receptor- mediated immune responses, but the molecular mechanisms of its action remain unclear. In this respect, the assessment of the relative and unique contribution of CD5 in cell signaling events is a crucial point. We have used Jurkat variants and anti-CD5 mAbs to show that the CD5 signaling pathway is distinct from that used by the TCR/CD3 complex. We hereby identify two independent mechanisms of CD5-mediated diacylglycerol release by virtue of their different kinetics: 1) an early and transient diacylglycerol increase that results from the activation of a phosphatidylcholine-specific phospholipase C, and 2) a late and sustained increase that requires de novo phospholipid synthesis. Studies performed on a TCR/CD3-deficient Jurkat cell variant indicate that only the CD5-mediated phosphatidylcholine-specific phospholipase C activation is dependent on TCR/CD3 expression. Mutational analyses of CD5 demonstrate that both mechanisms are dependent on the integrity of the CD5 distal cytoplasmic region. Our results show that CD5 is a signaling molecule per se that uses mechanisms resembling those used by some cytokine receptors (such as IL- 1 or TNF receptors) to modulate lymphocyte activation.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-R. Sarrias, M. Farnos, R. Mota, F. Sanchez-Barbero, A. Ibanez, I. Gimferrer, J. Vera, R. Fenutria, C. Casals, J. Yelamos, et al.
CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock
PNAS, July 10, 2007; 104(28): 11724 - 11729.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ibanez, M.-R. Sarrias, M. Farnos, I. Gimferrer, C. Serra-Pages, J. Vives, and F. Lozano
Mitogen-Activated Protein Kinase Pathway Activation by the CD6 Lymphocyte Surface Receptor
J. Immunol., July 15, 2006; 177(2): 1152 - 1159.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Sandra, M. Degli Esposti, K. Ndebele, P. Gona, D. Knight, M. Rosenquist, and R. Khosravi-Far
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Alters Mitochondrial Membrane Lipids
Cancer Res., September 15, 2005; 65(18): 8286 - 8297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Gimferrer, A. Ibanez, M. Farnos, M.-R. Sarrias, R. Fenutria, S. Rosello, P. Zimmermann, G. David, J. Vives, C. Serra-Pages, et al.
The Lymphocyte Receptor CD6 Interacts with Syntenin-1, a Scaffolding Protein Containing PDZ Domains
J. Immunol., August 1, 2005; 175(3): 1406 - 1414.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Gimferrer, M. Calvo, M. Mittelbrunn, M. Farnos, M. R. Sarrias, C. Enrich, J. Vives, F. Sanchez-Madrid, and F. Lozano
Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation
J. Immunol., August 15, 2004; 173(4): 2262 - 2270.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Arman, J. Calvo, M. E. Trojanowska, P. N. Cockerill, M. Santana, M. Lopez-Cabrera, J. Vives, and F. Lozano
Transcriptional Regulation of Human CD5: Important Role of Ets Transcription Factors in CD5 Expression in T Cells
J. Immunol., June 15, 2004; 172(12): 7519 - 7529.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Gimferrer, M. Farnos, M. Calvo, M. Mittelbrunn, C. Enrich, F. Sanchez-Madrid, J. Vives, and F. Lozano
The Accessory Molecules CD5 and CD6 Associate on the Membrane of Lymphoid T Cells
J. Biol. Chem., February 28, 2003; 278(10): 8564 - 8571.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. S. Azzam, J. B. DeJarnette, K. Huang, R. Emmons, C.-S. Park, C. L. Sommers, D. El-Khoury, E. W. Shores, and P. E. Love
Fine Tuning of TCR Signaling by CD5
J. Immunol., May 1, 2001; 166(9): 5464 - 5472.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Vila, J. Calvo, L. Places, O. Padilla, M. Arman, I. Gimferrer, C. Aussel, J. Vives, and F. Lozano
Role of Two Conserved Cytoplasmic Threonine Residues (T410 and T412) in CD5 Signaling
J. Immunol., January 1, 2001; 166(1): 396 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Gary-Gouy, P. Bruhns, C. Schmitt, A. Dalloul, M. Daeron, and G. Bismuth
The Pseudo-immunoreceptor Tyrosine-based Activation Motif of CD5 Mediates Its Inhibitory Action on B-cell Receptor Signaling
J. Biol. Chem., January 7, 2000; 275(1): 548 - 556.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Simarro, J. Calvo, J. M. Vila, L. Places, O. Padilla, J. Alberola-Ila, J. Vives, and F. Lozano
Signaling Through CD5 Involves Acidic Sphingomyelinase, Protein Kinase C-{zeta}, Mitogen-Activated Protein Kinase Kinase, and c-Jun NH2-Terminal Kinase
J. Immunol., May 1, 1999; 162(9): 5149 - 5155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Raman and R. P. Kimberly
Cutting Edge: Differential CD5-Dependent Regulation of CD5-Associated CK2 Activity in Mature and Immature T Cells: Implication on TCR/CD3-Mediated Activation
J. Immunol., December 1, 1998; 161(11): 5817 - 5820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Calvo, J. M. Vilda, L. Places, M. Simarro, O. Padilla, D. Andreu, K. S. Campbell, C. Aussel, and F. Lozano
Human CD5 Signaling and Constitutive Phosphorylation of C-Terminal Serine Residues by Casein Kinase II
J. Immunol., December 1, 1998; 161(11): 6022 - 6029.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Raman, A. Kuo, J. Deshane, D. W. Litchfield, and R. P. Kimberly
Regulation of Casein Kinase 2 by Direct Interaction with Cell Surface Receptor CD5
J. Biol. Chem., July 24, 1998; 273(30): 19183 - 19189.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.